查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585789

牛結核病診斷市場：按測試、按應用分類 - 2025-2030 年全球預測

Bovine Tuberculosis Diagnosis Market by Tests (Molecular Diagnostic Tests, Serological Tests, Traditional Tests), Application (Point-of-care, Veterinary Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年牛結核病診斷市值為8.2778億美元，預計到2024年將達到8.8785億美元，複合年成長率為7.74%，到2030年將達到13.9523億美元。

牛結核病（bTB）診斷是獸醫學的一個重要方面，可確保有效管理和控制這種通用感染疾病。 bTB 診斷的範圍包括多種診斷技術，例如皮膚試驗、血液檢查和分子診斷，每種技術的準確性、成本和實用性水平各不相同。 bTB 診斷主要應用於獸醫機構、公共衛生機構和農業部門，其中疾病監測、控制和根除至關重要。最終用途包括獸醫院、診斷實驗室、農場等。

主要市場統計
基準年[2023] 8.2778億美元
預測年份 [2024] 88785萬美元
預測年份 [2030] 13.9523 億美元
複合年成長率（%） 7.74%

結核病診斷市場受到結核病發病率增加、診斷技術進步、政府加大疾病控制力度等因素的影響。利用可攜式和數位診斷平台等技術進步，開發快速、經濟高效且高度準確的診斷工具的機會正在出現。對綜合疾病管理系統和即時診斷的需求提供了更多可能性。然而，市場開拓面臨先進診斷高成本、監管障礙以及新興市場認知度低等挑戰。透過降低成本和透過技術創新提高意識來解決這些限制將支持市場擴張。

就地檢驗、生物標記發現和基因檢測的創新是最有前途的研究和開發領域。此外，整合人工智慧來簡化流程並提高準確性也是一個有前途的途徑。市場競爭非常激烈，主要企業都專注於擴大產品系列和地理覆蓋範圍。為了利用市場機會，相關人員應專注於策略夥伴關係、研發投資以及提高意識的教育宣傳活動。優先考慮可提高診斷速度和準確性的經濟高效、擴充性的解決方案，可開拓新的細分市場並推動長期成長。

市場動態：快速發展的牛結核病診斷市場的關鍵市場洞察

牛結核病診斷市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 不斷成長的牛中細菌感染的盛行率不斷增加
    • 政府大力防治牛結核病
    • 新興國家的意識不斷增強
  • 市場限制因素
    • 測試結果不正確的問題
  • 市場機會
    • 牛結核病診斷解決方案的不斷進步
    • 動物消費增加和對安全畜產品的需求不斷成長
  • 市場挑戰
    • 牛結核病診斷的局限性

波特五力：駕馭牛結核病診斷市場的策略工具

波特的五力架構是了解牛結核病診斷市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對牛結核病診斷市場的外部影響

外部宏觀環境因素在塑造牛結核病診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解牛結核病診斷市場的競爭狀況

牛結核病診斷市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣牛結核病診斷市場供應商的績效評估

FPNV 定位矩陣是評估牛結核病診斷市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃牛結核病診斷市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對牛結核病診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 牛數量增加導致細菌感染蔓延
      • 政府為防治牛結核病所做的重要努力
      • 新興國家的意識不斷增強
    • 抑制因素
      • 測試結果不正確的問題
    • 機會
      • 牛結核病診斷解決方案的不斷進步
      • 動物消費量增加和對安全動物產品的需求不斷成長
    • 任務
      • 與牛結核病診斷相關的局限性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

牛牛結核病診斷市場測試

  • 分子診斷測試
  • 血清學檢測
  • 傳統測試

第7章牛結核病診斷市場：依應用分類

  • 照護現場
  • 獸醫診所

第8章北美和南美牛結核病診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區牛結核病診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲牛結核病診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AsureQuality Australia Pty Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioMerieux SA
  • Bionote USA Inc.
  • Boehringer Ingelheim GmbH
  • CZ Vaccines SAU
  • Enfer Group
  • F. Hoffmann-La Roche AG
  • IDEXX Laboratories, Inc.
  • Lionex GmbH
  • Pall Corporation
  • PBD Biotech Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Zoetis Inc.
Product Code: MRR-0D217D5AD942

The Bovine Tuberculosis Diagnosis Market was valued at USD 827.78 million in 2023, expected to reach USD 887.85 million in 2024, and is projected to grow at a CAGR of 7.74%, to USD 1,395.23 million by 2030.

Bovine Tuberculosis (bTB) diagnosis is a critical aspect of veterinary healthcare, ensuring effective management and control of this zoonotic disease. The scope of bTB diagnosis encompasses various diagnostic techniques, including skin testing, blood tests, and molecular diagnostics, with each method offering differing levels of accuracy, cost, and practicality. Its necessity lies in preventing the spread of bTB from cattle to humans and other animals, safeguarding both public health and the agricultural economy. bTB diagnostics are applied primarily in veterinary settings, public health institutions, and agricultural sectors where monitoring, controlling, and eradicating the disease are paramount. The end-use scope includes veterinary hospitals, diagnostic laboratories, and farms.

KEY MARKET STATISTICS
Base Year [2023] USD 827.78 million
Estimated Year [2024] USD 887.85 million
Forecast Year [2030] USD 1,395.23 million
CAGR (%) 7.74%

The market for bTB diagnostics is influenced by factors such as increasing incidences of bTB, advancements in diagnostic techniques, and rising governmental initiatives for disease control. Opportunities arise in developing rapid, cost-effective, and highly accurate diagnostic tools, leveraging technological advancements like portable and digital diagnostic platforms. Demand for integrated disease management systems and real-time diagnostics offers further potential. However, market growth faces challenges including the high cost of advanced diagnostics, regulatory hurdles, and limited awareness in developing regions. Addressing these limitations by reducing costs through innovation and increasing awareness can bolster market expansion.

Innovation in point-of-care testing, biomarker discovery, and genetic testing represents the best potential areas for research and development. Additionally, integrating artificial intelligence to streamline and enhance accuracy presents a promising avenue. The market is competitive, with significant players focused on expanding their product portfolios and geographical reach. To capitalize on market opportunities, stakeholders should focus on strategic partnerships, investment in R&D, and education campaigns for awareness. Prioritizing cost-effective, scalable solutions that enhance diagnostic speed and precision can unlock new market segments and drive long-term growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bovine Tuberculosis Diagnosis Market

The Bovine Tuberculosis Diagnosis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of bacterial infections in rising cattle population
    • Significant governmental efforts to combat bovine tuberculosis
    • Increasing awareness in emerging economies
  • Market Restraints
    • Issues relating to inappropriate test results
  • Market Opportunities
    • Ongoing advancements in bovine tuberculosis diagnostic solutions
    • Rising animal consumption and elevated demand for safe animal products
  • Market Challenges
    • Limitations associated with bovine tuberculosis diagnosis

Porter's Five Forces: A Strategic Tool for Navigating the Bovine Tuberculosis Diagnosis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bovine Tuberculosis Diagnosis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bovine Tuberculosis Diagnosis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bovine Tuberculosis Diagnosis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bovine Tuberculosis Diagnosis Market

A detailed market share analysis in the Bovine Tuberculosis Diagnosis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bovine Tuberculosis Diagnosis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bovine Tuberculosis Diagnosis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bovine Tuberculosis Diagnosis Market

A strategic analysis of the Bovine Tuberculosis Diagnosis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bovine Tuberculosis Diagnosis Market, highlighting leading vendors and their innovative profiles. These include AsureQuality Australia Pty Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioMerieux S.A., Bionote USA Inc., Boehringer Ingelheim GmbH, CZ Vaccines S.A.U., Enfer Group, F. Hoffmann-La Roche AG, IDEXX Laboratories, Inc., Lionex GmbH, Pall Corporation, PBD Biotech Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Bovine Tuberculosis Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Tests, market is studied across Molecular Diagnostic Tests, Serological Tests, and Traditional Tests.
  • Based on Application, market is studied across Point-of-care and Veterinary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of bacterial infections in rising cattle population
      • 5.1.1.2. Significant governmental efforts to combat bovine tuberculosis
      • 5.1.1.3. Increasing awareness in emerging economies
    • 5.1.2. Restraints
      • 5.1.2.1. Issues relating to inappropriate test results
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in bovine tuberculosis diagnostic solutions
      • 5.1.3.2. Rising animal consumption and elevated demand for safe animal products
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with bovine tuberculosis diagnosis
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bovine Tuberculosis Diagnosis Market, by Tests

  • 6.1. Introduction
  • 6.2. Molecular Diagnostic Tests
  • 6.3. Serological Tests
  • 6.4. Traditional Tests

7. Bovine Tuberculosis Diagnosis Market, by Application

  • 7.1. Introduction
  • 7.2. Point-of-care
  • 7.3. Veterinary Clinics

8. Americas Bovine Tuberculosis Diagnosis Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Bovine Tuberculosis Diagnosis Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Bovine Tuberculosis Diagnosis Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AsureQuality Australia Pty Ltd.
  • 2. Becton, Dickinson and Company
  • 3. Bio-Rad Laboratories, Inc.
  • 4. BioMerieux S.A.
  • 5. Bionote USA Inc.
  • 6. Boehringer Ingelheim GmbH
  • 7. CZ Vaccines S.A.U.
  • 8. Enfer Group
  • 9. F. Hoffmann-La Roche AG
  • 10. IDEXX Laboratories, Inc.
  • 11. Lionex GmbH
  • 12. Pall Corporation
  • 13. PBD Biotech Ltd.
  • 14. Takara Bio Inc.
  • 15. Thermo Fisher Scientific Inc.
  • 16. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. BOVINE TUBERCULOSIS DIAGNOSIS MARKET RESEARCH PROCESS
  • FIGURE 2. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BOVINE TUBERCULOSIS DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BOVINE TUBERCULOSIS DIAGNOSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. BOVINE TUBERCULOSIS DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023